Nicotine Polacrilex Lozenge
Natural health product licensed in Canada
- Other names
- Mini Nicotine Lozenge, Mini Nicotine Polacrilex Lozenge, Nic-Assist®, Nicotin Mini Lozenges, Nicotine Lozenge, Quit 4, Quit Nicotine Lozenge
- Licence holder
- Perrigo International, Inc.
- NPN or DIN-HM
- 80019550
- Status
- Active licence
- Licence date
- 14 June 2010
- Revision date
- 18 September 2026
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-propénoïque, 2-méthyl-, Polymère avec du diéthénylbenzène, mélangé avec de la 3-((2S)-1-méthyl-2-pyrrolinidinyl)pyridine Source : Nicotine polacrilex | 4 mg |
Non-medicinal ingredients
Bicarbonate de potassium, Carbonate de sodium, Sodium alginate, mannitol, Saveur de menthe poivrée, Stéarate de magnésium, calcium polycarbophil, Aspartame, Gomme de xanthane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Pastille | 10 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A medicine which can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. The effectiveness of this product is directly related to your motivation to stop smoking. Consult your pharmacist or doctor regarding the availability of smoking cessation programs in your area.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80019550
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.